Target expression details
Target's General Information | |||||
---|---|---|---|---|---|
Target ID | T89515 | ||||
Target Name | Polypeptide deformylase (PDF) | ||||
Synonyms | |||||
Target Type | Successful | ||||
Gene Name | |||||
Biochemical Class | CH-NH donor oxidoreductase | ||||
UniProt ID | DYR_HUMAN | ||||
Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
Disease | Acute myelocytic leukemia | ||||
Example drug | Aminopterin | Withdrawn from market | [1], [2] | ||
Tissue | Bone marrow | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.54 Z-score: -0.86 P-value: 8.87E-16 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Disease | Rheumatoid arthritis | ||||
Tissue | Synovial tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: 0.38 Z-score: 1.46 P-value: 1.08E-02 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Disease | Bladder cancer | ||||
Tissue | Bladder tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: 0.97 Z-score: 3.88 P-value: 5.11E-06 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
References | |||||
REF 1 | Drug information of Aminopterin, Health Canada, 2007. | ||||
REF 2 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.